Cure Profile News Today

Gulf International Bank UK Ltd trimmed its stake in NovoCure Limited (NASDAQ:NVCR – Get Rating) by 19.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 16,842 shares of the medical equipment provider’s stock after selling 4,000 shares during the quarter. […]

Parallel Advisors LLC lowered its position in shares of AtriCure, Inc. (NASDAQ:ATRC – Get Rating) by 45.9% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 4,317 shares of the medical device company’s stock after selling 3,660 shares during the quarter. Parallel Advisors LLC’s holdings in AtriCure […]